Technology: Scientific Publications

2021

Pili, M. et al.
Clinical development of a predictive biomarker with 58 tumor genes for dovitinib treatment of solid tumors
Poster presented at the ESMO 2021; 16 – 21 September 2021; Convened Virtually

Foegh, M. et al.
A novel drug response predictor (DRP) mRNA biomarker of the tumor response to the multi tyrosine kinase inhibitor dovitinib
Poster presented at the European Association for Cancer Research Virtual Congress 2021; 9 – 12 June 2021; Convened Virtually

2019

Kappel Buhl, A. et al.
Doxorubicin response prediction in neoadjuvant breast cancer therapy
Journal of Clinical Oncology 2019 37:15                  

Kappel Buhl, A. et al.
A drug response predictor to guide treatment for breast cancer
Pharmacogenomics, 2019 (Ahead of Print)

2011

Chen, J. et al.
A 71-gene signature of TRAIL sensitivity in cancer Cells
Mol Cancer Ther. 2011. 10.1158/1535-7163

Miller, I. et al.
Market access challenges in the EU for high value diagnostic tests
Personalized Medicine. 2011. 8(2): 137-148

Sign up for press releases

Sign up for press releases and receive relevant information about Allarity Therapeutics A/S.